在社区居住的老年人中,STOPPFall药物使用与正静性低血压之间的关联
Kate Doyle1,2,3, Siobhan Scarlett1, Frank Moriarty1,4
1The Irish Longitudinal Study on Ageing, Trinity College Dublin, Dublin, Ireland.
Age and ageing
|December 8, 2025
概括
在老年人中,服用两种或两种以上的降落风险增加药物 (FRID) 与延迟血压恢复和静止性低血压 (OH) 有关. 合理化FRID处方对于管理这一群体的OH至关重要.
科学领域:
- 老年学是指老年学的学科.
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
背景情况:
- 跌倒风险增加药物 (FRID) 与老年人跌倒风险增加有关.
- 静止性低血压 (OH) 是一个潜在的机制,将FRID与跌倒联系起来.
- 在高跌倒风险的老年人中,老年人处方的查工具 (STOPPFall) 识别了潜在的FRID.
研究的目的:
- 调查STOPPFall药物使用与社区居住的老年人 (≥65岁) 的OH之间的关联.
- 分析STOPPFall药物对站立后血压调节的影响.
主要方法:
- 静止血压 (BP) 是通过使用活跃支架与Finometer测量.
- STOPPFall药物从爱尔兰长距离老化研究 (TILDA) 数据中记录下来.
- 回归模型评估了STOPPFall药物与OH和正静血压变化的各种定义之间的关联.
主要成果:
- 两种或多种STOPPFall药物的处方独立地与延迟血压恢复",任何OH"和经典OH有关.
- 多种STOPPFall药物与静缩血压 (sBP) 显著降低在停顿后的30,60,90和120秒.
- 增加STOPPFall药物的使用与站立后30秒的低血压有关.
结论:
- 处方两种或两种以上的STOPPFall药物与老年人中延迟的BP恢复和OH显著相关.
- 合理化STOPPFall药物适用于患有OH的老年人.
- 这项研究强调了药物审查在预防与OH相关的跌倒方面的重要性.
相关概念视频
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
216
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
216
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
221
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
221
Alterations in Blood Pressure
1.9K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.9K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
183
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
183


